Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
La Revue Du Praticien
|
June 23, 2025
[Neurofibromatosis type 1: recent advances]
Laura Fertitta, Pierre Wolkenstein
International Journal of Dermatology
|
August 23, 2018
Cutaneous melioidosis: a review of the literature
Laura Fertitta, Gentiane Monsel, Joseph Torresi, et al.
Operative Neurosurgery (Hagerstown, Md.)
|
April 28, 2025
Surgical Management of Peripheral Nerve Schwannomas in Non-Neurofibromatosis Type 2 Schwannomatosis
Matthieu Peyre, Alix Addi, Béatrice Parfait, et al.
The American Journal of Dermatopathology
|
May 18, 2022
Eosinophilic Pustular Folliculitis of Infancy: A Histologic Assessment of 43 Cases
Laura Fertitta, Christine Bodemer, Thierry Molina, et al.
Journal of Patient-Reported Outcomes
|
May 29, 2024
Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex
Britt A E Dhaenens, Sarah A van Dijk, Laura Fertitta, et al.
The Journal of Investigative Dermatology
|
May 31, 2023
In-Hospital Clinical Features, Morbidity, and Mortality of Patients with Neurofibromatosis 1 in France: A Nationwide, Population-Based Retrospective Cohort Study
Emmanuelle Diaz, Christina Bergqvist, Bastien Peiffer, et al.
Acta Neuropathologica Communications
|
July 19, 2025
Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1
Pernelle Pulh, Fanny Coulpier, Audrey Onfroy, et al.
Genes
|
December 23, 2022
Bothnian Palmoplantar Keratoderma: Further Delineation of the Associated Phenotype
Laura Fertitta, Fabienne Charbit-Henrion, Stéphanie Leclerc-Mercier, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
June 18, 2023
Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant mice
Fanny Coulpier, Pernelle Pulh, Layna Oubrou, et al.
The Journal of Investigative Dermatology
|
February 18, 2024
Whole-Body Positron Emission Tomography with <sup>18</sup>F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1
Laura Fertitta, Arnaud Jannic, Ouidad Zehou, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
La Revue Du Praticien
|
June 23, 2025
[Neurofibromatosis type 1: recent advances]
Laura Fertitta, Pierre Wolkenstein
International Journal of Dermatology
|
August 23, 2018
Cutaneous melioidosis: a review of the literature
Laura Fertitta, Gentiane Monsel, Joseph Torresi, et al.
Operative Neurosurgery (Hagerstown, Md.)
|
April 28, 2025
Surgical Management of Peripheral Nerve Schwannomas in Non-Neurofibromatosis Type 2 Schwannomatosis
Matthieu Peyre, Alix Addi, Béatrice Parfait, et al.
The American Journal of Dermatopathology
|
May 18, 2022
Eosinophilic Pustular Folliculitis of Infancy: A Histologic Assessment of 43 Cases
Laura Fertitta, Christine Bodemer, Thierry Molina, et al.
Journal of Patient-Reported Outcomes
|
May 29, 2024
Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex
Britt A E Dhaenens, Sarah A van Dijk, Laura Fertitta, et al.
The Journal of Investigative Dermatology
|
May 31, 2023
In-Hospital Clinical Features, Morbidity, and Mortality of Patients with Neurofibromatosis 1 in France: A Nationwide, Population-Based Retrospective Cohort Study
Emmanuelle Diaz, Christina Bergqvist, Bastien Peiffer, et al.
Acta Neuropathologica Communications
|
July 19, 2025
Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1
Pernelle Pulh, Fanny Coulpier, Audrey Onfroy, et al.
Genes
|
December 23, 2022
Bothnian Palmoplantar Keratoderma: Further Delineation of the Associated Phenotype
Laura Fertitta, Fabienne Charbit-Henrion, Stéphanie Leclerc-Mercier, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
June 18, 2023
Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant mice
Fanny Coulpier, Pernelle Pulh, Layna Oubrou, et al.
The Journal of Investigative Dermatology
|
February 18, 2024
Whole-Body Positron Emission Tomography with <sup>18</sup>F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1
Laura Fertitta, Arnaud Jannic, Ouidad Zehou, et al.
Page
of 2